Clinical Study
The Relationship between NAFLD and Sarcopenia in Elderly Patients
Table 1
Clinical characteristics of the study population.
| | Sarcopenia | Nonsarcopenia |
| Number | 158 | 336 | Male/female | 87/71 | 129/207 | Hyperuricemia (%) | 18.99% | 20.24% | Diabetes (%) | 74.05% | 80.4% | Hypertension (%) | 56.32% | 56.55% | ALT (U/L) | 22.85 ± 21.42 | 22.08 ± 16.77 | AST (U/L) | 23.14 ± 14.71 | 22.16 ± 15.44 | HbA1c | 7.79 ± 2.33 | 8.2 ± 2.36 | TC (mmol/L) | 4.38 ± 2.80 | 4.32 ± 1.53 | TG (mmol/L) | 1.50 ± 1.83 | 1.71 ± 1.65 | HDL (mmol/L) | 1.26 ± 0.39 | 1.21 ± 0.38 | LDL (mmol/L) | 2.47 ± 0.90 | 2.58 ± 0.97 | NAFLD (%) | 22.15% | 37.20% | Excess hs-CRP (%) | 48.10% | 30.95% | Age (years) | 73.75 ± 8.52 | 70.12 ± 6.95 | BMI (kg/m2) | 22.13 ± 2.97 | 25.02 ± 3.34 |
|
|
|